Login

Tomorrow's Company interviews Roger Parry CBE, Chairman of YouGov plc and Oxford Metrics plc, as well as Peter Taylor. 00:10:00

Share On Facebook Share On Twitter

Imogen Moorhouse is CEO/Exec Dir at Oxford Metrics PLC. 

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Chairman and CEO of CITIC Capital Discusses China's Economic Strategy and Growth Outlook | Yichen Zhang, CEO , CITIC Capital Holding.
00:10:00
Building Resilience: Step 1 of 5 Vital Pandemic Moves | Wakefield Hare - Financial Planner, Greater Than Financial
00:10:00
Perennial Global Resources Trust Portfolio Manager Sam Berg Discusses Fund's Strategy
00:10:00
This VC Invests In Entrepreneurs Before They Start Companies|Alana Goyal,Founder and Managing Partner,base case capital
00:10:00
Founder and CEO Lew Cirne announces New Relic One, the industry's first entity-centric observability platform.
00:10:00
CEO Viktor Garmiani on Gaining Market Share in a Challenging Environment | Viktor Garmiani, CEO , Candles Scandinavia AB.
00:10:00
Recovery is defined differently at different treatment centers|Joanna Conti,CEO,VistaResearchInc
00:10:00
Emmanuel Roman on Why Now is the Time to Be Cautious in the Market|  Emmanuel Roman, CEO, PIMCO.
00:10:00
Unlock Financial Freedom with the Infinite Banking Concept
00:10:00
Climate Resilience Panel at Infraday Florida | Allan Marks - Partner of Milbank LLP
00:10:00
Promoting Inclusivity in the Workplace | Denis Horrigan, Partner and Co-founder of Connecticut Wealth Management
00:00:00
Soligenix Inc is a late-stage biopharmaceutical company - Christopher J. Schaber, PhD Chairman, President and Chief Executive Officer, Soligenix Inc

© 2017 - Neuhu+